| A novel phosphorylation by AMP-activated kinase regulates RUNX2 from ubiquitination in osteogenesis over adipogenesis S Chava, S Chennakesavulu, BM Gayatri, ABM Reddy Cell death & disease 9 (7), 754, 2018 | 60 | 2018 |
| LIMK2 promotes the metastatic progression of triple-negative breast cancer by activating SRPK1 P Malvi, R Janostiak, S Chava, P Manrai, E Yoon, K Singh, M Harigopal, ... Oncogenesis 9 (8), 77, 2020 | 29 | 2020 |
| The BRD9/7 inhibitor TP-472 blocks melanoma tumor growth by suppressing ECM-mediated oncogenic signaling and inducing apoptosis LD Mason, S Chava, KK Reddi, R Gupta Cancers 13 (21), 5516, 2021 | 28 | 2021 |
| Loss of HAT1 expression confers BRAFV600E inhibitor resistance to melanoma cells by activating MAPK signaling via IGF1R S Bugide, KR Parajuli, S Chava, R Pattanayak, DLD Manna, D Shrestha, ... Oncogenesis 9 (5), 44, 2020 | 25 | 2020 |
| Disruptor of telomeric silencing 1-like promotes ovarian cancer tumor growth by stimulating pro-tumorigenic metabolic pathways and blocking apoptosis S Chava, S Bugide, YJK Edwards, R Gupta Oncogenesis 10 (7), 48, 2021 | 19 | 2021 |
| Identification of the mutational landscape of gynecological malignancies S Chava, R Gupta Journal of Cancer 11 (16), 4870, 2020 | 15 | 2020 |
| High glutamine suppresses osteogenesis through mTORC1-mediated inhibition of the mTORC2/AKT-473/RUNX2 axis MB Gayatri, NN Gajula, S Chava, ABM Reddy Cell Death Discovery 8 (1), 277, 2022 | 14 | 2022 |
| Nutraceuticals and Their Role in Human Health and Disease A Devi, S Chennakesavulu, C Suresh, ABM Reddy Functional Food and Human Health, 375-403, 2018 | 13 | 2018 |
| Measurement of natural killer cell-mediated cytotoxicity and migration in the context of hepatic tumor cells S Chava, S Bugide, R Gupta, N Wajapeyee Journal of visualized experiments: JoVE, 10.3791/60714, 2020 | 12 | 2020 |
| Betacellulin promotes tumor development and EGFR mutant lung cancer growth by stimulating the EGFR pathway and suppressing apoptosis S Chava, S Bugide, X Zhang, R Gupta, N Wajapeyee Iscience 25 (5), 2022 | 10 | 2022 |
| HOXC6 drives a therapeutically targetable pancreatic cancer growth and metastasis pathway by regulating MSK1 and PPP2R2B P Malvi, S Chava, G Cai, K Hu, LJ Zhu, YJK Edwards, MR Green, R Gupta, ... Cell Reports Medicine 4 (11), 2023 | 9 | 2023 |
| Breaking tolerance to pancreatic cancer unresponsiveness to chemotherapy S Chava, MB Gayatri, AB Reddy London: Elsevier, 2019 | 8 | 2019 |
| LIMK2 promotes melanoma tumor growth and metastasis through G3BP1-ESM1 pathway-mediated apoptosis inhibition P Malvi, DS Reddy, R Kumar, S Chava, S Burela, K Parajuli, X Zhang, ... Oncogene 42 (18), 1478-1491, 2023 | 7 | 2023 |
| ATAD2 is a driver and a therapeutic target in ovarian cancer that functions by upregulating CENPE P Guruvaiah, S Chava, CW Sun, N Singh, CA Penn, R Gupta Cell Death & Disease 14 (7), 456, 2023 | 4 | 2023 |
| EMT contributes to chemoresistance in pancreatic cancer S Chava, MB Gayatri, ABM Reddy Breaking tolerance to pancreatic cancer unresponsiveness to chemotherapy, 25-43, 2019 | 3 | 2019 |
| Co-targeting of specific epigenetic regulators in combination with CDC7 potently inhibit melanoma growth S Chava, S Bugide, P Malvi, R Gupta Iscience 25 (8), 2022 | 1 | 2022 |
| ASAH1 facilitates TNBC by DUSP5 suppression-driven activation of MAP kinase pathway and represents a therapeutic vulnerability KK Reddi, S Chava, SC Chabattula, YJK Edwards, K Singh, R Gupta Cell Death & Disease 15 (6), 452, 2024 | | 2024 |
| TGF-β2/OPTN/FOXC1/miR-200 axis regulates intraocular pressure dynamics in trabecular meshwork cells CK Sugali, NN Gajula, S Chava, ABM Reddy bioRxiv, 2024.06. 06.593675, 2024 | | 2024 |
| AMPK-RUNX2-mTORC2 axis involved in EMT of MDA-MB-231 breast cancer cells AB Reddy, MB Gayatri, S Chava Cancer Research 79 (13_Supplement), 4305-4305, 2019 | | 2019 |
| Dynamic Regulation of RUNX2 and AMPK in metabolic disorders and stress S Chava Hyderabad, 0 | | |